CRISPR Therapeutics AG
(NASDAQ : CRSP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
0.20%282.851.4%$843.38m
AMGNAmgen, Inc.
0.00%220.861.3%$515.75m
CELGCelgene Corp.
-0.14%109.871.3%$466.13m
GILDGilead Sciences, Inc.
-0.34%64.851.0%$398.99m
VRTXVertex Pharmaceuticals, Inc.
-0.57%208.611.9%$312.11m
ILMNIllumina, Inc.
-0.68%303.903.5%$309.19m
REGNRegeneron Pharmaceuticals, Inc.
-1.28%340.472.6%$264.26m
EXASEXACT Sciences Corp.
-0.38%81.7424.0%$208.99m
ALXNAlexion Pharmaceuticals, Inc.
0.12%108.502.0%$180.02m
SGENSeattle Genetics, Inc.
0.83%115.706.1%$138.09m
BMRNBioMarin Pharmaceutical, Inc.
0.60%75.494.3%$124.38m
SRPTSarepta Therapeutics, Inc.
-0.31%97.1614.6%$115.02m
AAgilent Technologies, Inc.
-0.27%78.051.6%$101.09m
NBIXNeurocrine Biosciences, Inc.
1.27%114.495.0%$91.56m
BGNEBeiGene Ltd.
-0.52%197.232.1%$88.18m

Company Profile

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, and Shaun Patrick Foy in 2014 and is headquartered in Zug, Switzerland.